These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 20639458

  • 21. Bi-phased regulation of the post-transcriptional inflammatory response by Tristetraprolin levels.
    Mahmoud L, Moghrabi W, Khabar KSA, Hitti EG.
    RNA Biol; 2019 Mar; 16(3):309-319. PubMed ID: 30664390
    [Abstract] [Full Text] [Related]

  • 22. Molecular mechanism of LPS-induced TNF-α biosynthesis in polarized human macrophages.
    Schilling E, Weiss R, Grahnert A, Bitar M, Sack U, Hauschildt S.
    Mol Immunol; 2018 Jan; 93():206-215. PubMed ID: 29207327
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6.
    Van Tubergen EA, Banerjee R, Liu M, Vander Broek R, Light E, Kuo S, Feinberg SE, Willis AL, Wolf G, Carey T, Bradford C, Prince M, Worden FP, Kirkwood KL, D'Silva NJ.
    Clin Cancer Res; 2013 Mar 01; 19(5):1169-79. PubMed ID: 23349315
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cinnamon polyphenol extract affects immune responses by regulating anti- and proinflammatory and glucose transporter gene expression in mouse macrophages.
    Cao H, Urban JF, Anderson RA.
    J Nutr; 2008 May 01; 138(5):833-40. PubMed ID: 18424588
    [Abstract] [Full Text] [Related]

  • 29. The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway.
    Brooks SA, Connolly JE, Rigby WF.
    J Immunol; 2004 Jun 15; 172(12):7263-71. PubMed ID: 15187101
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR.
    Komnenov D, Scipione CA, Bazzi ZA, Garabon JJ, Koschinsky ML, Boffa MB.
    Thromb Haemost; 2015 Aug 15; 114(2):337-49. PubMed ID: 26062599
    [Abstract] [Full Text] [Related]

  • 32. Temporal regulation of cytokine mRNA expression by tristetraprolin: dynamic control by p38 MAPK and MKP-1.
    Prabhala P, Bunge K, Rahman MM, Ge Q, Clark AR, Ammit AJ.
    Am J Physiol Lung Cell Mol Physiol; 2015 May 01; 308(9):L973-80. PubMed ID: 25724669
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of protein kinase Cdelta reduces tristetraprolin expression by destabilizing its mRNA in activated macrophages.
    Leppänen T, Jalonen U, Korhonen R, Tuominen RK, Moilanen E.
    Eur J Pharmacol; 2010 Feb 25; 628(1-3):220-5. PubMed ID: 19925787
    [Abstract] [Full Text] [Related]

  • 34. Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3' untranslated region.
    Zhao W, Liu M, D'Silva NJ, Kirkwood KL.
    J Interferon Cytokine Res; 2011 Aug 25; 31(8):629-37. PubMed ID: 21457063
    [Abstract] [Full Text] [Related]

  • 35. Endothelial dysfunction in tristetraprolin-deficient mice is not caused by enhanced tumor necrosis factor-α expression.
    Bollmann F, Wu Z, Oelze M, Siuda D, Xia N, Henke J, Daiber A, Li H, Stumpo DJ, Blackshear PJ, Kleinert H, Pautz A.
    J Biol Chem; 2014 May 30; 289(22):15653-65. PubMed ID: 24727475
    [Abstract] [Full Text] [Related]

  • 36. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
    Dai XY, Cai Y, Sun W, Ding Y, Wang W, Kong W, Tang C, Zhu Y, Xu MJ, Wang X.
    Cardiovasc Res; 2014 Feb 01; 101(2):297-305. PubMed ID: 24253523
    [Abstract] [Full Text] [Related]

  • 37. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin.
    Stoecklin G, Tenenbaum SA, Mayo T, Chittur SV, George AD, Baroni TE, Blackshear PJ, Anderson P.
    J Biol Chem; 2008 Apr 25; 283(17):11689-99. PubMed ID: 18256032
    [Abstract] [Full Text] [Related]

  • 38. Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation.
    Kratochvill F, Machacek C, Vogl C, Ebner F, Sedlyarov V, Gruber AR, Hartweger H, Vielnascher R, Karaghiosoff M, Rülicke T, Müller M, Hofacker I, Lang R, Kovarik P.
    Mol Syst Biol; 2011 Dec 20; 7():560. PubMed ID: 22186734
    [Abstract] [Full Text] [Related]

  • 39. Macrophage inflammation resolution requires CPEB4-directed offsetting of mRNA degradation.
    Suñer C, Sibilio A, Martín J, Castellazzi CL, Reina O, Dotu I, Caballé A, Rivas E, Calderone V, Díez J, Nebreda AR, Méndez R.
    Elife; 2022 Apr 20; 11():. PubMed ID: 35442882
    [Abstract] [Full Text] [Related]

  • 40. Tristetraprolin recruits functional mRNA decay complexes to ARE sequences.
    Hau HH, Walsh RJ, Ogilvie RL, Williams DA, Reilly CS, Bohjanen PR.
    J Cell Biochem; 2007 Apr 15; 100(6):1477-92. PubMed ID: 17133347
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.